Centessa Pharmaceuticals to Join the Morgan Stanley 22nd Annual Global Healthcare Conference
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company dedicated to discovering and developing transformative medicines for patients, has announced that its management team will participate in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference. This important event will feature a scheduled fireside chat.
Event Details
The fireside chat is set for 1:05 PM ET on September 4th. Those interested can tune in to the live audio webcast of this event, as well as access archived recordings, which will be available in the “Events and Publications” section of the Centessa Pharmaceuticals website.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals is committed to developing groundbreaking medicines that have the potential to transform treatment approaches. The company is advancing several programs, including those focused on hemophilia, narcolepsy, and innovations in immuno-oncology, utilizing their proprietary LockBody technology platform. Each initiative is pursued with the belief that it could redefine care standards.
Ongoing Research and Innovations
With a strong emphasis on enhancing patient outcomes, Centessa is actively involved in numerous promising research initiatives. The company is dedicated to creating innovative solutions that could significantly improve lives.
Contact Information
For more information, please reach out to Kristen K. Sheppard, Esq., Senior Vice President of Investor Relations, via email at investors@centessa.com.
Frequently Asked Questions
What is the Morgan Stanley Global Healthcare Conference?
The Morgan Stanley Global Healthcare Conference is a significant event where various healthcare companies showcase their innovations and business developments.
What is Centessa Pharmaceuticals known for?
Centessa Pharmaceuticals is recognized for its dedication to developing transformative medicines, particularly in the areas of hemophilia and sleep disorders.
How can I access the live webcast of the conference?
The live webcast will be accessible in the “Events and Publications” section on the Centessa Pharmaceuticals investor relations website.
Who can I contact for more information about Centessa Pharmaceuticals?
For additional information, you can contact Kristen K. Sheppard, Esq., Senior Vice President of Investor Relations.
What types of programs does Centessa Pharmaceuticals have?
Centessa has several advanced programs, including those targeting hemophilia, narcolepsy, and therapies in immuno-oncology.